References
- Global Cancer Observatory https://gco.iarc.fr/ Accessed 01 Feb 2022. Lyon, France: GLOBOCAN Database, IARC (International Agency for Research in Cancer); 2020.
- NOM 041-SSA2-2011: norma Oficial Mexicana para la prevención, diagnóstico, tratamiento, control y vigilancia epidemiológica del cáncer de mama. Secretaría de Salud, México 2011. Available online: http://dof.gob.mx/nota_detalle.php?codigo=5194157&fecha=09/06/2011 Accessed 01 Feb 2022.
- Global Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) results. Seattle (United States): Institute for Health Metrics and Evaluation (IHME; 2020.
- Gomez-Dantes H, Fullman N, Lamadrid-Figueroa H, Cahuana-Hurtado L, Darney B, Avila-Burgos L, Correa-Rotter R, Rivera JA, Barquera S, Gonzalez-Pier E, et al. Dissonant health transition in the states of Mexico, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2016;388(10058):2386–9. doi:10.1016/S0140-6736(16)31773-1.
- Gomez Dantes O, Sesma S, Becerril VM, Knaul FM, Arreola H, Frenk J. The health system of Mexico. Salud Publica Mex. 2011; 53(Suppl 2): s220–232. https://saludpublica.mx/index.php/spm/article/view/5043/10023.
- González Block MA, Reyes Morales H, Cahuana Hurtado L, Balandrán A, Méndez E, Allin S. Mexico: health system review. Health Systems in Transition. 2020;22:i–222.
- Aracena-Genao B, Gonzalez-Robledo MC, Gonzalez-Robledo LM, Palacio-Mejia LS, Nigenda-Lopez G. Fund for protection against catastrophic expenses. Salud Publica Mex. 2011;53(Suppl 4):407–15. doi:10.1590/s0036-36342011001000004.
- Chemor Ruiz A, Ratsch AEO, Alamilla Martinez GA. Mexico’s Seguro Popular: achievements and challenges. Health Syst Reform. 2018;4(3):194–202. doi:10.1080/23288604.2018.1488505.
- Catálogo Universal de Servicios de Salud. 2018. Anexo I: intervenciones del Fondo de Protección contra Gastos Catastróficos. Mexico: Comisión Nacional de Protección en Salud http://www.documentos.seguro-popular.gob.mx/dgss/CAUSES_2018c.pdf Accessed 01 Feb 2022.
- Kale R. The treatment gap. Epilepsia. 2002;43(Suppl 6):31–33. doi:10.1046/j.1528-1157.43.s.6.13.x.
- Kohn R, Ali AA, Puac-Polanco V, Figueroa C, Lopez-Soto V, Morgan K, Saldivia S, Vicente B. Mental health in the Americas: an overview of the treatment gap. Rev Panam Salud Publica. 2018;42:e165. doi:10.26633/RPSP.2018.165. PMC6386160.
- Evans-Lacko S, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Benjet C, Bruffaerts R, Chiu WT, Florescu S, de Girolamo G, Gureje O, et al. Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO world mental health (WMH) surveys. Psychol Med. 2018;48(9):1560–71. doi:10.1017/S0033291717003336. PMC6878971.
- Reich MR. Restructuring health reform, Mexican style. Health Syst Reform. 2020;6(1):1–11. doi:10.1080/23288604.2020.1763114.
- Agren D. Farewell Seguro Popular. Lancet. 2020;395(10224):549–50. doi:10.1016/S0140-6736(20)30408-6.
- Instituto de Salud para el Bienestar, Gobierno de México. ( Cited 2021May16) Available at: https://www.gob.mx/insabi/que-hacemos.
- INEGI (Instituto Nacional de Estadística y Geografía). XII Censo General de Población y Vivienda 2000, México [ cited 2021 May 2]. Available from: https://inegi.org.mx/programas/ccpv/2000/.
- INEGI (Instituto Nacional de Estadística y Geografía). Censo de Población y Vivienda 2010, México [ cited 2021 May 2]. Available from: https://inegi.org.mx/programas/ccpv/2010/.
- INEGI (Instituto Nacional de Estadística y Geografía). Encuesta Intercensal 2015, México (cited 2021 May 2). Available from: https://www.inegi.org.mx/programas/intercensal/2015/.
- ENSANUT (Encuesta Nacional de Salud y Nutrición) 2006. Instituto Nacional de Salud Pública, México. [Cited 2021 May 2]. Available from: https://ensanut.insp.mx/encuestas/ensanut2006/descargas.php.
- ENSANUT (Encuesta Nacional de Salud y Nutrición) 2012. Instituto Nacional de Salud Pública, México. [Cited 2021 May 2]. Available from: https://ensanut.insp.mx/encuestas/ensanut2012/descargas.php.
- Global Burden of Disease Collaborative Network. Global burden of disease study 2017 (GBD 2017) results. Seattle (United States): Institute for Health Metrics and Evaluation (IHME), 2018. (cited 2021 May 3) Available from http://ghdx.healthdata.org/gbd-results-tool.
- Reynoso-Noveron N, Villarreal-Garza C, Soto-perez-de-celis E, Arce-Salinas C, Matus-Santos J, Ramirez-Ugalde MT, Alvarado-Miranda A, Cabrera-Galeana P, Meneses-Garcia A, Lara-Medina F, et al. Clinical and Epidemiological profile of breast cancer in Mexico: results of the Seguro Popular. J Glob Oncol. 2017;3(6):757–64. doi:10.1200/JGO.2016.007377. PMC5735969.
- Lozano R, Garrido F. Improving health system efficiency: Mexico. Catastrophic health expenditure fund https://apps.who.int/iris/handle/10665/186476 . . 2015 (Geneva: World Health Organization) Accessed 2 May 2021 Health Systems Governance and Funding
- Unger-Saldana K, Ventosa-Santaularia D, Miranda A, Verduzco-Bustos G. Barriers and explanatory mechanisms of delays in the patient and diagnosis intervals of care for breast cancer in Mexico. Oncologist. 2018;23(4):440–53. doi:10.1634/theoncologist.2017-0431. PMC5896704.
- Huerta-Gutierrez R, Lajous M, Zamora-Muñoz S, Hernández-Ávila JE, Mohar A, Muñoz-Aguirre P. Breast cancer survival disparities in Mexican women under a comprehensive health reform. JCO Global Oncology. 2020;6(Supplement_1):67–67. doi:10.1200/go.20.64000.
- Bandala-Jacques A, Huerta-Gutierrez R, Muñoz SZ, Cabrera P, Mohar A, Lajous M. Abstract 47: survival of breast cancer in women treated under Mexico’s Seguro Popular. Cancer Epidemiol Biomarker and Prev. 2021;30(7_Supplement):47–47. doi:10.1158/1538-7755.ASGCR21-47.
- Villarreal-Garza C, Aranda-Gutierrez A, Ferrigno AS, Platas A, Aloi-Timeus I, Mesa-Chavez F, Ayensa-Alonso A, Platas A. The challenges of breast cancer care in Mexico during health-care reforms and COVID-19. Lancet Oncol. 2021;22(2):170–71. doi:10.1016/S1470-2045(20)30609-4. PMC8080161.